Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo and Positive Controlled, Parallel Group Trial to Investigate the Effect of Multiple Doses of NOMAC-E2 on QT/QTc Interval in Healthy Women

NCT00779532 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00779532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00779532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo and Positive Controlled, Parallel Group Trial to Investigate the Effect of Multiple Doses of NOMAC-E2 on QT/QTc Interval in Healthy Women
Lead sponsor
Organon and Co
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2008
Completion date
November 30, 2008
Enrollment
189 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contraception